|
Volumn 73, Issue 2, 2015, Pages 310-311
|
The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NON PRESCRIPTION DRUG;
ARTICLE;
BREAST FEEDING EDUCATION;
CLINICAL DECISION MAKING;
CLINICAL PRACTICE;
COMMUNICATION SKILL;
DRUG ABSORPTION;
DRUG INDUSTRY;
DRUG LABELING;
DRUG LEGISLATION;
DRUG USE;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LACTATION;
MEDICAL INFORMATION;
PATIENT CARE;
PATIENT COUNSELING;
PREGNANCY;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK FACTOR;
UNITED STATES;
DRUG EFFECTS;
HEALTH CARE POLICY;
LEGISLATION AND JURISPRUDENCE;
MANAGEMENT;
TRENDS;
DRUG LABELING;
FEMALE;
HEALTH POLICY;
HUMANS;
LACTATION;
PHYSICIAN'S PRACTICE PATTERNS;
POLICY MAKING;
PREGNANCY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84937402227
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2015.04.026 Document Type: Editorial |
Times cited : (6)
|
References (8)
|